Cholangiocarcinoma: all 930 studies

Page 5 of 10. Open to participants first (292), then studies with results posted, then the rest; newest registration first within each.

• Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract CancerCompletedNCT00753675Phase 2Results posted
• Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar CholangiocarcinomaCompletedNCT00721175Phase 4Results posted
• Liver Transplantation for CholangiocarcinomaTerminatedNCT00708877Not applicableResults posted
• A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary CancersCompletedNCT00660699Phase 2Results posted
• Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By SurgeryCompletedNCT00553332Phase 2Results posted
• Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by SurgeryTerminatedNCT00478140Phase 2Results posted
• Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerTerminatedNCT00387348Phase 3Results posted
• Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary TumorsCompletedNCT00356889Phase 2Results posted
• Oxaliplatin and Capecitabine in Patients With Unresectable CholangiocarcinomaCompletedNCT00338988Phase 2Results posted
• Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract CancerCompletedNCT00107536Phase 2Results posted
• Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00101036Phase 2Results posted
• Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or GallbladderTerminatedNCT00085410Phase 2Results posted
• S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00033540Phase 2Results posted
• Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious SedationCompletedNCT07704021
• AI Multimodal Model for Liver Cancer Diagnosis and PrognosisActive, not recruitingNCT07658586
• Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic CholangiocarcinomaActive, not recruitingNCT07646717Phase 2
• Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced CholangiocarcinomaCompletedNCT07619937Phase 2
• A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic CholangiocarcinomaCompletedNCT07479264
• Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant TumorsCompletedNCT07319767
• HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICCCompletedNCT07304388Phase 2
• An Exosomal miRNA-based Liquid Biopsy for ICC DetectionCompletedNCT07225452
• Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.CompletedNCT07224737
• Interventional AI-Human Collaboration for Liver Tumor DiagnosisCompletedNCT07153783Not applicable
• Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract CancerSuspendedNCT07146646Phase 2
• Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
• Streamlining Radioembolization for Intrahepatic CholangiocarcinomaTerminatedNCT07043348
• Laparotomy, Laparoscopy, da Vinci SystemCompletedNCT07034495
• A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationActive, not recruitingNCT07023731Phase 1/2
• Contribution of the EyeMAX™ 11Fr (Micro-Tech) Digital Single-Operator Cholangioscope With a Wide Working ChannelCompletedNCT06933576
• Implementing a Randomized Control Trial to Test the Expanded Web-based Decision AidActive, not recruitingNCT06910670Not applicable
• Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of NepalCompletedNCT06888401
• A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid TumorsActive, not recruitingNCT06777316Phase 1/2
• Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCATerminatedNCT06739252Phase 2
• The Future Management of Patients With Neoplasms of the Gastro-intestinal TractActive, not recruitingNCT06728358Not applicable
• Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract CancerActive, not recruitingNCT06717464Phase 2
• The Expression of CD24 "do-not-eat-me" Signal in CholangiocarcinomaActive, not recruitingNCT06707025
• A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal MalignanciesWithdrawnNCT06690281Phase 2
• Role of Adjuvant Chemotherapy in Distal CholangiocarcinomaCompletedNCT06671431
• Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 2
• Outcomes and Prognostic Factors in HepatopancreatoduodenectomyCompletedNCT06631352
• A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsActive, not recruitingNCT06607185Phase 1
• The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic CholangiocarcinomaWithdrawnNCT06572189Early Phase 1
• Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly PatientsCompletedNCT06570174Not applicable
• Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.Active, not recruitingNCT06506955Phase 2/3
• NXP800 for the Treatment of Patients With Advanced or Metastatic CholangiocarcinomaTerminatedNCT06420349Phase 1
• A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsCompletedNCT06399757Phase 1
• Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)CompletedNCT06381648
• First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAICTerminatedNCT06370663Phase 2
• EchoTip AcuCore Post-Market Clinical StudyCompletedNCT06358001
• Extent of Intrahepatic Infiltration of Perihilar CholangiocarcinomaCompletedNCT06357117
• A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsTerminatedNCT06336148Phase 1
• Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced MalignancyTerminatedNCT06290856
• A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic CholangiocarcinomaCompletedNCT06290739
• An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor PatientsWithdrawnNCT06284226Early Phase 1
• MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary CancersCompletedNCT06258824
• HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic CholangiocarcinomaActive, not recruitingNCT06239532Phase 2
• Effect of PVE on Surgical Outcomes and Long-term Survival in Perihilar CholangiocarcinomaCompletedNCT06222619
• Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic CholangiocarcinomaActive, not recruitingNCT06178588Phase 2
• Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract CancerActive, not recruitingNCT06178445Phase 2
• Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene AlterationsActive, not recruitingNCT06160752Phase 1
• Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)Active, not recruitingNCT06109779Phase 3
• Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)Active, not recruitingNCT06048133Phase 2
• Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic CholangiocarcinomaWithdrawnNCT06017297Phase 2
• Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar CholangiocarcinomaCompletedNCT05993429
• Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic PatientsCompletedNCT05989789Not applicable
• A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7SuspendedNCT05958199Phase 1
• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in CholangiocarcinomaActive, not recruitingNCT05948475Phase 3
• HMPL-453 Food Effect and PPI Study in Healthy Volunteer StudyCompletedNCT05930119Phase 1
• Senior Adult Hepatobiliary Prehab StudyActive, not recruitingNCT05921552Not applicable
• Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic CholangiocarcinomaStatus unknownNCT05913661Phase 2
• An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic CholangiocarcinomaActive, not recruitingNCT05876754Phase 3
• IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid TumorTerminatedNCT05814536Phase 1
• IMM2902 in Patients With Advanced Solid Tumors Expressing HER2Status unknownNCT05805956Phase 1/2
• A Study of CDX-585 in Patients With Advanced MalignanciesCompletedNCT05788484Phase 1
• Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICCActive, not recruitingNCT05781958Phase 2
• Domvanalimab and Zimberelimab in Advanced Liver CancersActive, not recruitingNCT05724563Phase 2
• Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma PatientsStatus unknownNCT05721963
• Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic CholangiocarcinomaStatus unknownNCT05697237Not applicable
• Preoperative Evaluation of Lymph Nodes of CholangiocarcinomaCompletedNCT05678218
• FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination TherapyStatus unknownNCT05662488
• Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After PancreatoduodenectomyStatus unknownNCT05641233Phase 1/2
• Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma PatientsStatus unknownNCT05634694
• MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar CholangiocarcinomaStatus unknownNCT05626127
• Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.Status unknownNCT05620498Phase 2
• Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary CancerStatus unknownNCT05596370
• An Exploratory Clinical Study of Photodynamic Therapy Combined With Sonodynamic Therapy in CholangiocarcinomaStatus unknownNCT05580328Not applicable
• Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/RearrangementsTerminatedNCT05565794Phase 2
• Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)Active, not recruitingNCT05564403Phase 2
• 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsTerminatedNCT05563272Phase 2
• Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBDActive, not recruitingNCT05519605
• FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1CompletedNCT05518071Phase 2
• Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC TrialWithdrawnNCT05514912Phase 2
• Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/AmplificationWithdrawnNCT05510427Phase 1
• A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)Active, not recruitingNCT05506943Phase 2/3
• HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic CholangiocarcinomaCompletedNCT05489692
• The PLATON NetworkTerminatedNCT05489250
• Minimally Invasive Pancreatoduodenectomy for Distal CholangiocarcinomaCompletedNCT05478889
• Study on the Quality of Life (QoL) After Liver SurgeryCompletedNCT05464706Not applicable
• Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
• An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic CholangiocarcinomaStatus unknownNCT05448183Phase 2

← Cholangiocarcinoma overview